Document is current
Any future updates will be listed below
-
Authors
Maslowski, Sarah
Hohenstein, Sven
Bollmann, Andreas
Karagiannidis, Christian
Papan, Cihan
Thal, Serge C.
Wirth, Stefan
Tenenbaum, Tobias
Aydin, Malik
-
Funding
Funding for this research was provided by:
Private Universität Witten/Herdecke gGmbH
- License Information
-
More Information
Article History
Received: 23 April 2024
Accepted: 28 August 2024
First Online: 10 September 2024
Declarations
:
: All protocols and analyses were in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Furthermore, a positive ethics approval was obtained from the Witten/Herdecke University, Germany (S-18/2022). An informed consent was not necessary due to the retrospective origin of the article.
: Not applicable.
: TT has received third-party research funding from Sanofi. He has received payment for presentations from Sanofi and Pfizer. He is a member of the Advisory Boards of Sanofi and MSD.The authors declare that they have no conflict of interest. The research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
